These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18367362)

  • 1. Estimation and characterisation of budesonide tablets impurities.
    Ferraboschi P; Bertacche V; Maccone I; Pini E; Ragonesi L; Venturini A; Stradi R
    J Pharm Biomed Anal; 2008 Jul; 47(3):636-40. PubMed ID: 18367362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitfalls and success of experimental design in the development of a mixed MEKC method for the analysis of budesonide and its impurities.
    Furlanetto S; Orlandini S; Giannini I; Beretta G; Pinzauti S
    Electrophoresis; 2009 Feb; 30(4):633-43. PubMed ID: 19248147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing and optimizing a validated isocratic reversed-phase high-performance liquid chromatography separation of nimodipine and impurities in tablets using experimental design methodology.
    Barmpalexis P; Kanaze FI; Georgarakis E
    J Pharm Biomed Anal; 2009 Jul; 49(5):1192-202. PubMed ID: 19369025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of related impurities in megestrol acetate.
    Guo F; Feng H; Wang Y; Zhang C; Li Y
    J Pharm Biomed Anal; 2006 Jun; 41(4):1418-22. PubMed ID: 16616448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of tablets containing the antihistamine loratadine: a contribution to the identification of impurities].
    Issa N; Mlynárová M
    Ceska Slov Farm; 2004 Jul; 53(4):192-6. PubMed ID: 15369231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and structural elucidation of process impurities generated in the end-game synthesis of taranabant (MK-0364) via cyanuric chloride.
    Chen YW; Liu Y; Novak T; Frey L; Campos K; Klapars A; Chen CY; Phenix B
    J Pharm Biomed Anal; 2009 Apr; 49(3):702-10. PubMed ID: 19188037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets.
    Kadav AA; Vora DN
    J Pharm Biomed Anal; 2008 Sep; 48(1):120-6. PubMed ID: 18583084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic determination of epimers, impurities, and content of the glucocorticoid budesonide and preparation of primary standard.
    Roth G; Wikby A; Nilsson L; Thalén A
    J Pharm Sci; 1980 Jul; 69(7):766-70. PubMed ID: 7391935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
    Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
    J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
    Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K
    J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of the presence of iminodibenzyl in carbamazepine tablets].
    Mamolo MG; Vio L; Maurich V
    Boll Chim Farm; 1984 Oct; 123(10):465-76. PubMed ID: 6529490
    [No Abstract]   [Full Text] [Related]  

  • 12. Grapefruit juice interaction with oral budesonide: equal effect on immediate-release and delayed-release formulations.
    Seidegård J; Randvall G; Nyberg L; Borgå O
    Pharmazie; 2009 Jul; 64(7):461-5. PubMed ID: 19694184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The profiling of MDMA tablets: a study of the combination of physical characteristics and organic impurities as sources of information.
    Milliet Q; Weyermann C; Esseiva P
    Forensic Sci Int; 2009 May; 187(1-3):58-65. PubMed ID: 19345026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concerning a contaminated drug].
    Franco Patiño R
    Rev Invest Clin; 1996; 48(3):247. PubMed ID: 8966387
    [No Abstract]   [Full Text] [Related]  

  • 17. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
    Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
    J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease.
    Dilger K; Halter J; Bertz H; Lopez-Lazaro L; Gratwohl A; Finke J
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):336-43. PubMed ID: 19203724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prochlorperazine tablets repackaged into dose administration aids: can the patient be assured of quality?
    Glass B; Mangan M; Haywood A
    J Clin Pharm Ther; 2009 Apr; 34(2):161-9. PubMed ID: 19250136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.